| 注册
首页|期刊导航|中国输血杂志|负载自体肿瘤抗原的DC-CIK细胞联合自体造血干细胞移植治疗难治性淋巴瘤的临床研究

负载自体肿瘤抗原的DC-CIK细胞联合自体造血干细胞移植治疗难治性淋巴瘤的临床研究

苏毅 邵文军 闵敏 李莉 陈健 范方教 易海 付利 刘阳阳 邓涛 孙浩平 孙薏 钟国成

中国输血杂志2009,Vol.22Issue(10):802-805,4.
中国输血杂志2009,Vol.22Issue(10):802-805,4.

负载自体肿瘤抗原的DC-CIK细胞联合自体造血干细胞移植治疗难治性淋巴瘤的临床研究

Autologous tumor cell lysate-loaded dendritic cells and cytokine-induced killer cells in combination with autologous hematopoietic stem cell transplatation in the treatment of refractory lymphoma

苏毅 1邵文军 2闵敏 2李莉 2陈健 2范方教 1易海 1付利 1刘阳阳 1邓涛 1孙浩平 2孙薏 2钟国成2

作者信息

  • 1. 成都军区总医院,血液科,四川,成都,610088
  • 2. 解放军452医院,血液肿瘤科
  • 折叠

摘要

Abstract

Objective To study the efficacy and side effect of autologons tumor cell lysate-loaded DC-CIK plus autologous hematopoietic stem cell transplantation in the treatment of refractory lymphoma.Methods Thirty-five cases of refractory lymphoma were recruited,lymphoma antigen-pulsed autologous DE-CIK cells were infused 5-10 days after the MAC conditioning regimen.Results Out of the 35 Cases,complete remission Was achieved in 29(82.8%),partial remission in 4(14.4%).Two patients died during transplantation due to severe mixed infections,with a transplant-related mortality rate of 5.7%.All cases of complete remission and partial remission were followed-up for 3-49 months,4 cases with partial remission died 3,6,10,13 months after transplantation.Three cases with complete remission relapsed 11,17,20 months after transplantation.and the other 26 cases survived until now.Conclusion Autologous tumor cell lysate-loaded DE-CIK combined with autologous hematopoietic stem cell transplantation in the treatment of refractory lymphoma is safe and effective.

关键词

淋巴瘤/DC/CIK/白体造血干细胞/移植/细胞治疗

Key words

Lymphoma DE CIK/Autologous hematopoieric stem cell transplantation/Cell therapy

分类

医药卫生

引用本文复制引用

苏毅,邵文军,闵敏,李莉,陈健,范方教,易海,付利,刘阳阳,邓涛,孙浩平,孙薏,钟国成..负载自体肿瘤抗原的DC-CIK细胞联合自体造血干细胞移植治疗难治性淋巴瘤的临床研究[J].中国输血杂志,2009,22(10):802-805,4.

中国输血杂志

OA北大核心CSCDCSTPCD

1004-549X

访问量0
|
下载量0
段落导航相关论文